Clinical Trials Directory

Trials / Completed

CompletedNCT00620893

Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Bp Consulting, Inc · Network
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will evaluate and compare 2 artificial tears in their ability to reduce post LASIK dry eye signs and symptoms. The secondary endpoint of this study is to evaluate refractive regression in these patients. The 'Refractive Outcome' data point will be defined as the difference between the post-op spherical equivalent (SE) and the pre-op targeted SE.

Conditions

Interventions

TypeNameDescription
DRUGPEG- 400 based artificial tearBaseline: Instill one drop in the randomized eye four times daily starting the day after surgery can be used more frequently if needed Month 3: Instill one drop in the randomized eye twice daily
DRUGSystaneBaseline: Instill one drop in the randomized eye four times daily starting the day after surgery can be used more frequently if needed Month 3: Instill one drop in the randomized eye twice daily

Timeline

Start date
2008-02-01
Primary completion
2009-05-01
Completion
2009-05-01
First posted
2008-02-22
Last updated
2009-09-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00620893. Inclusion in this directory is not an endorsement.